CN105079757A - Traditional Chinese medicine composition for treating emphysema - Google Patents
Traditional Chinese medicine composition for treating emphysema Download PDFInfo
- Publication number
- CN105079757A CN105079757A CN201510554673.6A CN201510554673A CN105079757A CN 105079757 A CN105079757 A CN 105079757A CN 201510554673 A CN201510554673 A CN 201510554673A CN 105079757 A CN105079757 A CN 105079757A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- rhizoma
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating emphysema. The traditional Chinese medicine composition comprises the following raw herbal materials by weight: 5 to 25 parts of rhizome pinelliae preparata, 5 to 25 parts of dried orange peel, 5 to 25 parts of poria cocos, 5 to 20 parts of almond, 5 to 20 parts of bulbus fritillariae cirrhosae, 5 to 20 parts of common coltsfoot flower, 5 to 20 parts of aster, 5 to 20 parts of radix stemonae, 5 to 25 parts of balloon flower, 5 to 20 parts of rhizoma anemarrhenae, 10 to 40 parts of astragalus membranaceus, 5 to 20 parts of Chinese angelica, 10 to 30 parts of ginseng, 5 to 25 parts of Chinese yam, 5 to 20 parts of shizandra berry, 5 to 20 parts of mangnolia officinalis, 5 to 20 parts of purple perilla, 5 to 20 parts of cinnamomum cassia, 5 to 20 parts of rhizoma zingiberis, 5 to 20 parts of roasted ephedra, and 5 to 15 parts of liquorice. The traditional Chinese medicine composition has the efficacies of invigorating spleen to quiet heart, moistening lung to descend qi, clearing heat-fire, and calming the adverse-rising energy to relieve asthma, has an obvious curative effect on treating emphysema, and is reliable in function.
Description
Technical field
The present invention relates to a kind of pharmaceutical product not determining structure of traditional herbal medicines, especially one treats emophysematous Chinese medicine composition.
Background technology
Emphysema refer to the air flue elasticity attenuation of terminal bronchiole far-end (alveolar bronchiole, alveolar duct, alveolar sac and alveolar), and excessive expansion, inflation and Pulmonary volume increase or simultaneously with the pathological state that airway walls is destroyed.Emphysema are commonly encountered diseases, and be the special pathological changes of one of pulmonary, emophysematous symptom is various, and weight also varies.At present, clinical treatment emphysema commonly use infection, cough-relieving, eliminate the phlegm, the medicine such as to relieving asthma, and after patient takes medicine, though symptom makes moderate progress, can produce dependency, be unable to do without medicine, the physical and mental health of grievous injury patient throughout the year.
The traditional Chinese medical science is thought, emphysema are many by YIN-deficiency of both the heart and lung, and yang hyperactivity is got angry, caused by lung-heat QI rising in reverse order.
According to theory of Chinese medical science, for emophysematous pathogeny, adopt the method for the treatment of of spleen reinforcing lung moistening, clearing away heat-fire, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
There is the strong deficiency of drug dependence to overcome existing clinical treatment emphysema, the invention provides a kind of prepare easy, cost is low, the emophysematous Chinese medicine composition for the treatment of that is evident in efficacy, that have no side effect.
The technical solution adopted for the present invention to solve the technical problems is: one treats emophysematous Chinese medicine composition, it is characterized in that: its raw material of Chinese medicine and weight are: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 5-25 part, Pericarpium Citri Reticulatae 5-25 part, Poria 5-25 part, Semen Armeniacae Amarum 5-20 part, Bulbus Fritillariae Cirrhosae 5-20 part, Flos Farfarae 5-20 part, Radix Asteris 5-20 part, Radix Stemonae 5-20 part, Radix Platycodonis 5-25 part, Rhizoma Anemarrhenae 5-20 part, Radix Astragali 10-40 part, Radix Angelicae Sinensis 5-20 part, Radix Ginseng 10-30 part, Rhizoma Dioscoreae 5-25 part, Fructus Schisandrae Chinensis 5-20 part, Cortex Magnoliae Officinalis 5-20 part, Fructus Perillae 5-20 part, Cortex Cinnamomi 5-20 part, Rhizoma Zingiberis 5-20 part, Herba Ephedrae (processed) 5-20 part, Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: one treats emophysematous Chinese medicine composition, it is characterized in that: its raw material of Chinese medicine and weight are: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 15 parts, Pericarpium Citri Reticulatae 15 parts, 15 parts, Poria, 10 parts, Semen Armeniacae Amarum, Bulbus Fritillariae Cirrhosae 10 parts, Flos Farfarae 12 parts, Radix Asteris 12 parts, the Radix Stemonae 12 parts, Radix Platycodonis 15 parts, the Rhizoma Anemarrhenae 12 parts, the Radix Astragali 30 parts, Radix Angelicae Sinensis 12 parts, Radix Ginseng 20 parts, Rhizoma Dioscoreae 15 parts, Fructus Schisandrae Chinensis 10 parts, Cortex Magnoliae Officinalis 10 parts, Fructus Perillae 10 parts, Cortex Cinnamomi 10 parts, Rhizoma Zingiberis 10 parts, Herba Ephedrae (processed) 10 parts, 10 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) has drying dampness to eliminate phlegm
,effect of stopping nausea and vomiting by lowering the adverse flow of QI; Pericarpium Citri Reticulatae has effect of diuretic, drying dampness to eliminate phlegm in regulating qi-flowing for strengthening spleen, tune; Poria has effect of promoting diuresis to eliminate damp pathogen, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming; Effect that Semen Armeniacae Amarum has expelling phlegm for arresting cough, intestine moistening of relievining asthma, the therapeutic method to keep the adverse QI flowing downwards open numbness; Bulbus Fritillariae Cirrhosae has clearing heat and moistening lung, effect of preventing phlegm from forming and stopping coughing; Flos Farfarae has nourishing the lung to keep the adverse QI downward, the effect of the antitussive that reduces phlegm; Radix Asteris has effect of nourishing the lung to keep the adverse QI downward, preventing phlegm from forming and stopping coughing; The Radix Stemonae has effect of nourishing the lung to keep the adverse QI downward, cough-relieving, parasite killing; Radix Platycodonis has lung qi dispersing and eliminates the phlegm, fosters the spirit of nobility and enrich blood, sharp the five internal organs, mend effect of five kinds of over strain; The Rhizoma Anemarrhenae has clearing away heat-fire, effect of moisturizing of promoting the production of body fluid; The Radix Astragali has effect that benefiting QI for strengthening the superficies, arresting sweating are admittedly de-, hold in the palm skin ulcer granulation promoting, inducing diuresis to remove edema; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, menstruction regulating and pain relieving, effect of loosening bowel to relieve constipation; Radix Ginseng has strongly invigorating primordial QI, multiple arteries and veins takes off admittedly, effect of invigorating the spleen to benefit the lung; Rhizoma Dioscoreae has strengthening the spleen and tonifying the lung, stomach reinforcing the kidney invigorating, benefit of reinforcing the kidney essence, hearing-improing and eyesight improving, help the five internal organs, bone and muscle strengthening, long will are calmed the nerves, effect of life lengthening; Fructus Schisandrae Chinensis has effect of astringent or styptic treatment for spontaneous sweating, the supplementing QI for promoting the production of body fluid of convergence, kidney calming; Cortex Magnoliae Officinalis has circulation of qi promoting removing food stagnancy, dampness except effect that is full, lowering the adverse QI to relieve asthma; Fructus Perillae has sending down the abnormal ascending QI expectorant, relievings asthma, effect of intestine moistening; Cortex Cinnamomi has mends fiery supporing yang, dispersing cold for relieving pain, promoting blood circulation to restore menstrual flow effect; Rhizoma Zingiberis has warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, effect of warming the lung to resolve fluid-retention; Herba Ephedrae (processed) has effect of relieving the exterior syndrome by diaphoresis, depressed lung-energy dispersing; Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component, through dialectical compatibility, helps using mutually assistant, plays effect of spleen reinforcing mind calming, nourishing the lung to keep the adverse QI downward, clearing away heat-fire, lowering the adverse QI to relieve asthma altogether, reach treating both the principal and secondary aspects of a disease to emophysematous treatment.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopts the use that is decocted in water for oral dose.Through clinical practice checking, it is reliably evident in efficacy, mild in medicine property and, do not occur toxic and side effects, effective percentage reaches 93%, cure rate 63%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
One treats emophysematous Chinese medicine composition, and its raw material of Chinese medicine and weight proportion are: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 15g, Pericarpium Citri Reticulatae 15g, Poria 15g, Semen Armeniacae Amarum 10g, Bulbus Fritillariae Cirrhosae 10 parts, Flos Farfarae 12g, Radix Asteris 12g, Radix Stemonae 12g, Radix Platycodonis 15g, Rhizoma Anemarrhenae 12g, Radix Astragali 30g, Radix Angelicae Sinensis 12g, Radix Ginseng 20g, Rhizoma Dioscoreae 15g, Fructus Schisandrae Chinensis 10g, Cortex Magnoliae Officinalis 10g, Fructus Perillae 10g, Cortex Cinnamomi 10g, Rhizoma Zingiberis 10g, Herba Ephedrae (processed) 10g, Radix Glycyrrhizae 10g.
Embodiment 2
One treats emophysematous Chinese medicine composition, and its raw material of Chinese medicine and weight proportion are: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 10g, Pericarpium Citri Reticulatae 25g, Poria 5g, Semen Armeniacae Amarum 20g, Bulbus Fritillariae Cirrhosae 12 parts, Flos Farfarae 15g, Radix Asteris 5g, Radix Stemonae 20g, Radix Platycodonis 10g, Rhizoma Anemarrhenae 15g, Radix Astragali 10g, Radix Angelicae Sinensis 20g, Radix Ginseng 15g, Rhizoma Dioscoreae 25g, Fructus Schisandrae Chinensis 5g, Cortex Magnoliae Officinalis 15g, Fructus Perillae 12g, Cortex Cinnamomi 20g, Rhizoma Zingiberis 5g, Herba Ephedrae (processed) 15g, Radix Glycyrrhizae 12g.
Embodiment 3
One treats emophysematous Chinese medicine composition, and its raw material of Chinese medicine and weight proportion are: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 20g, Pericarpium Citri Reticulatae 10g, Poria 25g, Semen Armeniacae Amarum 5g, Bulbus Fritillariae Cirrhosae 20 parts, Flos Farfarae 10g, Radix Asteris 15g, Radix Stemonae 10g, Radix Platycodonis 20g, Rhizoma Anemarrhenae 10g, Radix Astragali 25g, Radix Angelicae Sinensis 5g, Radix Ginseng 30g, Rhizoma Dioscoreae 10g, Fructus Schisandrae Chinensis 15g, Cortex Magnoliae Officinalis 5g, Fructus Perillae 20g, Cortex Cinnamomi 12g, Rhizoma Zingiberis 15g, Herba Ephedrae (processed) 5g, Radix Glycyrrhizae 15g.
Embodiment 4
One treats emophysematous Chinese medicine composition, and its raw material of Chinese medicine and weight proportion are: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 5g, Pericarpium Citri Reticulatae 20g, Poria 10g, Semen Armeniacae Amarum 15g, Bulbus Fritillariae Cirrhosae 5 parts, Flos Farfarae 20g, Radix Asteris 10g, Radix Stemonae 15g, Radix Platycodonis 5g, Rhizoma Anemarrhenae 20g, Radix Astragali 10g, Radix Angelicae Sinensis 15g, Radix Ginseng 10g, Rhizoma Dioscoreae 20g, Fructus Schisandrae Chinensis 12g, Cortex Magnoliae Officinalis 20g, Fructus Perillae 5g, Cortex Cinnamomi 15g, Rhizoma Zingiberis 12g, Herba Ephedrae (processed) 20g, Radix Glycyrrhizae 8g.
Embodiment 5
One treats emophysematous Chinese medicine composition, and its raw material of Chinese medicine and weight proportion are: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 25g, Pericarpium Citri Reticulatae 5g, Poria 20g, Semen Armeniacae Amarum 12g, Bulbus Fritillariae Cirrhosae 15 parts, Flos Farfarae 5g, Radix Asteris 20g, Radix Stemonae 10g, Radix Platycodonis 25g, Rhizoma Anemarrhenae 5g, Radix Astragali 40g, Radix Angelicae Sinensis 10g, Radix Ginseng 25g, Rhizoma Dioscoreae 5g, Fructus Schisandrae Chinensis 20g, Cortex Magnoliae Officinalis 12g, Fructus Perillae 15g, Cortex Cinnamomi 5g, Rhizoma Zingiberis 20g, Herba Ephedrae (processed) 12g, Radix Glycyrrhizae 6g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and covers powder, soaks 15 ~ 20 minutes, then adds water and do not have powder about 6 centimetres, carries out first time to decoct, and adopts intense fire to decoct, with slow fire boiling 20 ~ 30 minutes after boiling at a simmer; Second time decocts, and adds water and does not have powder about 4 centimetres, decocts 15 ~ 20 minutes after water boils.Decoct extracting juice twice, merge.
The present invention treats emophysematous Chinese medicine composition with the one given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 100 example, man 54 example, female 46 example, 45 ~ 75 years old age.
Two, diagnostic criteria:
(1) medical history such as chronic bronchitis, bronchial asthma, is had;
(2), fall ill slowly, have protopathy symptom as coughed, coughing up phlegm.In early days, breathe hard during work, and increase the weight of with disease progression, and with tired, lose weight and DB;
(3), early stage Non Apparent Abnormality body weight, typical person has barrel chest, and respiratory movement weakens, and voice, vocal fremitus weaken, and lung repercussion strengthens, and tripe voiced sound circle moves down, and border of cardiac dullness reduces, diminished breath sound, prolonged expiration;
(4), chest X-ray has lung field transmittance to strengthen, and lung peripheral vessels reduces, attenuates, and diaphram declines, flattens, and mobility weakens, and podiod is vertical, long and narrow, or has pulmonary belb;
(5), pulmonary function test shows residual volume RV/total lung capacity (RV/TLC) > 35%, forced expiratory volume in first second/forced vital capacity (FEV1/FVC) < 60%, maximal voluntary ventilation (MBC) accounts for predicted value percentage ratio < 80%, and oxygen uptake is pulmonary N2 emptying rate > 2.5% after 7 minutes.
Three, usage and dosage: during clinical practice, potion on the one, decocting twice extracting juice is about 400ml, point morning, late twice empty stomach decoction being taken warmly.It within seven days, is a course for the treatment of.Treatments period is avoided cold and uncooked food the thing of pungent stimulation.
Four, criterion of therapeutical effect:
(1), fully recover: cough, uncomfortable in chest, breathe hard, the sings and symptoms such as dyspnea disappears;
(2), effective: cough, uncomfortable in chest, breathe hard, the sings and symptoms such as dyspnea alleviates or obviously alleviates;
(3), invalid: symptom and sign are not improved.
Five, therapeutic effect: in this clinical observation case, takes medicine 2-6 the course for the treatment of, and recovery from illness 63 example, follows up a case by regular visits to and have no recurrence; Effective 30 examples, invalid 7 examples.There is not toxic and side effects in treatments period.
Six, model case:
Case 1: bring up certain, female, 49 years old.Suffered from chronic bronchitis after diagnosing before 2 years, transferred emphysema to afterwards, dyspnea, uncomfortable in chest, cough, expectoration, asthma.Time serious, cough, expectoration, tachypnea increase the weight of, and amount of expectoration increases, and expectorant becomes purulence, with the dry moist rales etc. generated heat, pulmonary's audible is intensive.Take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, the symptom such as dyspnea, uncomfortable in chest, cough, expectoration alleviates; Continue to take 3 courses for the treatment of, recovery from illness.
Case 2: Sui, man, 54 years old.Patient's spasmodic cough is had a surplus for 1 year, and recent cough with asthma increases the weight of, dynamic then breathe heavily more anxious.Abundant expectoration and rare clearly, time be white foam, two lung is heard and asthma ring sound.Be diagnosed as in hospital: emphysema, take western medicine and do not feel any better.Take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, symptom is clearly better; Continue to take 2 courses for the treatment of of treatment, all symptoms disappear completely, cure.Follow up a case by regular visits to half a year without recurrence.
Claims (2)
1. treat an emophysematous Chinese medicine composition, it is characterized in that: its raw material of Chinese medicine and weight are: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 5-25 part, Pericarpium Citri Reticulatae 5-25 part, Poria 5-25 part, Semen Armeniacae Amarum 5-20 part, Bulbus Fritillariae Cirrhosae 5-20 part, Flos Farfarae 5-20 part, Radix Asteris 5-20 part, Radix Stemonae 5-20 part, Radix Platycodonis 5-25 part, Rhizoma Anemarrhenae 5-20 part, Radix Astragali 10-40 part, Radix Angelicae Sinensis 5-20 part, Radix Ginseng 10-30 part, Rhizoma Dioscoreae 5-25 part, Fructus Schisandrae Chinensis 5-20 part, Cortex Magnoliae Officinalis 5-20 part, Fructus Perillae 5-20 part, Cortex Cinnamomi 5-20 part, Rhizoma Zingiberis 5-20 part, Herba Ephedrae (processed) 5-20 part, Radix Glycyrrhizae 5-15 part.
2. one according to claim 1 treats emophysematous Chinese medicine composition, it is characterized in that: its raw material of Chinese medicine and weight are: Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 15 parts, Pericarpium Citri Reticulatae 15 parts, 15 parts, Poria, 10 parts, Semen Armeniacae Amarum, Bulbus Fritillariae Cirrhosae 10 parts, Flos Farfarae 12 parts, Radix Asteris 12 parts, the Radix Stemonae 12 parts, Radix Platycodonis 15 parts, the Rhizoma Anemarrhenae 12 parts, the Radix Astragali 30 parts, Radix Angelicae Sinensis 12 parts, Radix Ginseng 20 parts, Rhizoma Dioscoreae 15 parts, Fructus Schisandrae Chinensis 10 parts, Cortex Magnoliae Officinalis 10 parts, Fructus Perillae 10 parts, Cortex Cinnamomi 10 parts, Rhizoma Zingiberis 10 parts, Herba Ephedrae (processed) 10 parts, 10 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510554673.6A CN105079757A (en) | 2015-05-17 | 2015-09-04 | Traditional Chinese medicine composition for treating emphysema |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510248528 | 2015-05-17 | ||
| CN201510554673.6A CN105079757A (en) | 2015-05-17 | 2015-09-04 | Traditional Chinese medicine composition for treating emphysema |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105079757A true CN105079757A (en) | 2015-11-25 |
Family
ID=54561676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510554673.6A Pending CN105079757A (en) | 2015-05-17 | 2015-09-04 | Traditional Chinese medicine composition for treating emphysema |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105079757A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105343558A (en) * | 2015-12-24 | 2016-02-24 | 赵红 | Traditional Chinese medicine preparation for treating emphysema |
| CN105878996A (en) * | 2016-05-26 | 2016-08-24 | 张晓燕 | Traditional Chinese medicine composition for treating emphysema |
| CN108200930A (en) * | 2018-02-11 | 2018-06-26 | 芜湖张恒春药业有限公司 | A kind of preventing phlegm from forming and stopping coughing cake and preparation method thereof |
| CN111513378A (en) * | 2020-04-03 | 2020-08-11 | 枣庄学院 | Novel coronary pneumonia virus protective clothing for public culture space prevention and treatment |
| CN111867412A (en) * | 2020-04-03 | 2020-10-30 | 枣庄学院 | Novel coronary pneumonia virus protective clothing for public culture space prevention and treatment |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11147834A (en) * | 1997-11-18 | 1999-06-02 | Noevir Co Ltd | Serine protease inhibitor |
| CN1686243A (en) * | 2005-04-15 | 2005-10-26 | 刘高生 | Chinese medicinal formula for treating chronic bronchitis |
-
2015
- 2015-09-04 CN CN201510554673.6A patent/CN105079757A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11147834A (en) * | 1997-11-18 | 1999-06-02 | Noevir Co Ltd | Serine protease inhibitor |
| CN1686243A (en) * | 2005-04-15 | 2005-10-26 | 刘高生 | Chinese medicinal formula for treating chronic bronchitis |
Non-Patent Citations (2)
| Title |
|---|
| 杨丽珍: "《常用中药中西医结合临床应用手册》", 30 June 1998, 江西科学技术出版社 * |
| 王莉等: "苏子降气汤临床运用体会", 《河南中医》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105343558A (en) * | 2015-12-24 | 2016-02-24 | 赵红 | Traditional Chinese medicine preparation for treating emphysema |
| CN105878996A (en) * | 2016-05-26 | 2016-08-24 | 张晓燕 | Traditional Chinese medicine composition for treating emphysema |
| CN108200930A (en) * | 2018-02-11 | 2018-06-26 | 芜湖张恒春药业有限公司 | A kind of preventing phlegm from forming and stopping coughing cake and preparation method thereof |
| CN111513378A (en) * | 2020-04-03 | 2020-08-11 | 枣庄学院 | Novel coronary pneumonia virus protective clothing for public culture space prevention and treatment |
| CN111867412A (en) * | 2020-04-03 | 2020-10-30 | 枣庄学院 | Novel coronary pneumonia virus protective clothing for public culture space prevention and treatment |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341064B (en) | Chinese medicine composition for treating urine retention | |
| CN105079757A (en) | Traditional Chinese medicine composition for treating emphysema | |
| CN103316141B (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN103463588B (en) | A kind of Chinese medicine composition for the treatment of sinking of QI of middle-JIAO | |
| CN103211990A (en) | Chinese medicinal composition for treating oral ulcer | |
| CN105079444A (en) | Traditional Chinese medicine composition for treating bronchial asthma | |
| CN103041271B (en) | Traditional Chinese medicine composition for treating emphysema | |
| CN103316250B (en) | Traditional Chinese medicine composition for treating cardiopalmus | |
| CN104771652A (en) | Vertigo treating traditional Chinese medicine composition | |
| CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
| CN103705900A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN103212039B (en) | Traditional Chinese medicine composition for treating infantile cough caused by qi deficiency | |
| CN105395982A (en) | Traditional Chinese medicine composition for curing chronic gastritis | |
| CN104888133A (en) | Traditional Chinese medicine composition for treatment of coronary heart disease | |
| CN104173932A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN102284023A (en) | Chinese medicinal composition for treating asthma | |
| CN105250955A (en) | Chinese herb composition for treating emphysema | |
| CN103028063B (en) | Traditional Chinese medicine composition for treating nephropathy | |
| CN105853799A (en) | Traditional Chinese medicine composition for treating pulmonary emphysema | |
| CN104127709A (en) | Traditional Chinese medicinal composition for curing chronic renal insufficiency | |
| CN104758888A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN105770374A (en) | Traditional Chinese medicine composition for treating uterine fibroid | |
| CN105998738A (en) | Traditional Chinese medicinal composition for treating night sweat | |
| CN105816603A (en) | Traditional Chinese medicine composition for treating postpartum hemorrhage | |
| CN105362596A (en) | Traditional Chinese medicine for treating pulmonary emphysema and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151125 |